BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 10595584)

  • 1. Comparative cleavage sites within the reactive-site loop of native and oxidized alpha1-proteinase inhibitor by selected bacterial proteinases.
    Rapala-Kozik M; Potempa J; Nelson D; Kozik A; Travis J
    Biol Chem; 1999 Oct; 380(10):1211-6. PubMed ID: 10595584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of alpha1-proteinase inhibitor as a broad screen for detecting proteolytic activities in unknown samples.
    Nelson D; Potempa J; Travis J
    Anal Biochem; 1998 Jul; 260(2):230-6. PubMed ID: 9657883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid inactivation of alpha-1-proteinase inhibitor by neutrophil specific leukolysin/membrane-type matrix metalloproteinase 6.
    Nie J; Pei D
    Exp Cell Res; 2004 Jun; 296(2):145-50. PubMed ID: 15149845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of human plasma serine proteinase inhibitors (serpins) by limited proteolysis of the reactive site loop with snake venom and bacterial metalloproteinases.
    Kress LF
    J Cell Biochem; 1986; 32(1):51-8. PubMed ID: 2429973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different susceptibility of elastase inhibitors to inactivation by proteinases from Staphylococcus aureus and Pseudomonas aeruginosa.
    Sponer M; Nick HP; Schnebli HP
    Biol Chem Hoppe Seyler; 1991 Nov; 372(11):963-70. PubMed ID: 1686554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate specificity of Xenopus matrix metalloproteinase stromelysin-3.
    Amano T; Fu L; Sahu S; Markey M; Shi YB
    Int J Mol Med; 2004 Aug; 14(2):233-9. PubMed ID: 15254771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The P6-P2 region of serpins is critical for proteinase inhibition and complex stability.
    Chaillan-Huntington CE; Gettins PG; Huntington JA; Patston PA
    Biochemistry; 1997 Aug; 36(31):9562-70. PubMed ID: 9236002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transferable tail: fusion of the N-terminal acidic extension of heparin cofactor II to alpha1-proteinase inhibitor M358R specifically increases the rate of thrombin inhibition.
    Sutherland JS; Bhakta V; Filion ML; Sheffield WP
    Biochemistry; 2006 Sep; 45(38):11444-52. PubMed ID: 16981704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of mouse macrophage elastase with native and oxidized human alpha 1-proteinase inhibitor.
    Banda MJ; Clark EJ; Sinha S; Travis J
    J Clin Invest; 1987 May; 79(5):1314-7. PubMed ID: 3494748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrolysis of alanine oligomers and of elastin by P. aeruginosa proteinases and thermolysin.
    Saulnier J; Thevenon F; Besson C; Duclos MC; Wallach JM
    Biochem Int; 1991 Mar; 23(5):875-84. PubMed ID: 1909126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of polynucleotides on the inhibition of neutrophil elastase by mucus proteinase inhibitor and alpha 1-proteinase inhibitor.
    Belorgey D; Bieth JG
    Biochemistry; 1998 Nov; 37(46):16416-22. PubMed ID: 9819234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate specificity determinants of human macrophage elastase (MMP-12) based on the 1.1 A crystal structure.
    Lang R; Kocourek A; Braun M; Tschesche H; Huber R; Bode W; Maskos K
    J Mol Biol; 2001 Sep; 312(4):731-42. PubMed ID: 11575928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divergent effects of alpha1-antitrypsin on neutrophil activation, in vitro.
    Janciauskiene S; Zelvyte I; Jansson L; Stevens T
    Biochem Biophys Res Commun; 2004 Mar; 315(2):288-96. PubMed ID: 14766206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of human matrix metalloproteinases by various bacterial proteinases.
    Okamoto T; Akaike T; Suga M; Tanase S; Horie H; Miyajima S; Ando M; Ichinose Y; Maeda H
    J Biol Chem; 1997 Feb; 272(9):6059-66. PubMed ID: 9038230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cleavage and inactivation of alpha 1-antitrypsin by metalloproteinases released from neutrophils.
    Vissers MC; George PM; Bathurst IC; Brennan SO; Winterbourn CC
    J Clin Invest; 1988 Aug; 82(2):706-11. PubMed ID: 2841359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of protease activity in human otitis media.
    Avidano MA; Cotter CS; Stringer SP; Schultz GS
    Otolaryngol Head Neck Surg; 1998 Oct; 119(4):346-51. PubMed ID: 9781988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and characterization of a novel cysteine proteinase (periodontain) from Porphyromonas gingivalis. Evidence for a role in the inactivation of human alpha1-proteinase inhibitor.
    Nelson D; Potempa J; Kordula T; Travis J
    J Biol Chem; 1999 Apr; 274(18):12245-51. PubMed ID: 10212191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antielastase screen of the lower respiratory tract.
    Bieth JG
    Eur J Respir Dis Suppl; 1985; 139():57-61. PubMed ID: 3876235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of neutrophil cathepsin G by oxidized mucus proteinase inhibitor. Effect of heparin.
    Boudier C; Cadène M; Bieth JG
    Biochemistry; 1999 Jun; 38(26):8451-7. PubMed ID: 10387091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing the local conformational change of alpha1-antitrypsin.
    Baek JH; Im H; Kang UB; Seong KM; Lee C; Kim J; Yu MH
    Protein Sci; 2007 Sep; 16(9):1842-50. PubMed ID: 17660256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.